CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia.

CONCLUSION: CD25 is an independent prognostic factor in elderly AML patients. Alternative therapies for CD25-positive elderly AML patients are needed. PMID: 28097942 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28097942?dopt=Abstract

Source: Hematology - January 19, 2017 Category: Hematology Tags: Hematology Source Type: research